Effective July 14, 2023, the Board of Directors of ThermoGenesis Holdings, Inc. increased the size of the Board of Directors from five to seven directors and approved the appointment of Biao Xi, Ph.D. and James Xu, Esq., DBA, PsyD., CPA to the Board of Directors. Dr. Xi and Dr. Xu were nominated for appointment as directors by Boyalife Asset Holding II, Inc., pursuant to the First Amended and Restated Nomination and Voting Agreement, dated April 16, 2018, which is filed as Exhibit 10.3 to the Company?s Current Report on Form 8-K filed on April 18, 2018. The nomination was unanimously approved by the Board of Directors.

Since March 2022, Dr. Xi has served as Chief Scientific Officer, Co-founder, and member of the Board of Miracure Biotechnology, a San Diego based, early-stage drug discovery company developing new drug candidates for oncology and immunology applications. From 2018 to 2021, Dr. Xi served as Chief Executive Officer at ImmunePoint Inc. and Vice President of Translational Study at Theragene Pharmaceuticals. From 2006 to 2018, he was Chief Scientist for China at ACEA Biosciences, an Agilent company.

Dr. Xi was a Research Assistant Professor at Albert Einstein College of Medicine from 1999 through 2006. He earned a master?s degree from the Chinese Academy of Sciences and a Ph.D from Zhejiang University in China. Dr. Xu is a practicing attorney and licensed CPA in the State of Illinois.

He is also a Patent Lawyer licensed by United States Patent and Trademark Office and has been practicing patent, corporate and tax law for more than 25 years. Previously, from November 2016 to December 2019, Dr. Xu served as a member of ThermoGenesis Holdings, Inc.?s Board of Directors. Dr. Xu received a Master of Science in Electrical Engineering and an MBA from the University of Mississippi, J.D. and LLM degrees in Taxation from DePaul Law School, an LLM in Intellectual Property Law and LLM in Information Technologies from John Marshall Law School, a Psy.D. from California Southern University, and a DBA from University of Missouri-St.

Louis.